Current Psychiatry Reports, published by Springer, is a premier academic journal dedicated to the dissemination of cutting-edge research in the field of psychiatry and mental health. With a significant impact factor reflecting its esteemed position at Q1 in Psychiatry, this journal ranks an impressive #35 out of 567 in its category, placing it within the 93rd percentile of psychiatric publications as per Scopus metrics. Since its inception in 1996, it has provided a vital platform for clinicians, researchers, and students to explore and discuss contemporary psychiatric issues, advancements, and methodologies. While Current Psychiatry Reports is a subscription-based journal, its robust scholarly contributions are invaluable for practitioners and scholars looking to stay abreast of developments and empirical studies that shape the field. Based in the United States, at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, it remains an authoritative source for evidence-based insights that guide both research and clinical practice in mental health.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, a premier academic journal published by TAYLOR & FRANCIS LTD, stands at the forefront of interdisciplinary research in the fields of Biological Psychiatry, Psychiatry, and Mental Health. Based in the United Kingdom, this esteemed journal (ISSN: 1562-2975; E-ISSN: 1814-1412) has become increasingly influential since its inception in 2000, with a remarkable impact factor that reflects its high-quality research contributions. The journal is consistently ranked in the Q1 and Q2 categories across various relevant indices, demonstrating its reputation for excellence within the academic community. With Scopus rankings placing it in the top 20th percentile for Psychiatry and Mental Health, the WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY serves as a vital resource for researchers, professionals, and students seeking to further their understanding of the intricate relationship between biological processes and psychiatric phenomena. Despite being a traditional access journal, it possesses a robust scope that encompasses groundbreaking studies, reviews, and advancements in the understanding of mental health disorders, underlining its importance as a key reference in the advancement of psychiatric science and therapeutic practices.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE is a distinguished publication in the field of Psychiatry and Mental Health, published by TAYLOR & FRANCIS LTD in the United Kingdom. With an impressive 2023 impact factor that places it in the Q2 category among its peers, this journal is an essential resource for researchers, clinicians, and students dedicated to advancing mental health practices and understanding psychiatric disorders. Covering topics from clinical studies to innovative treatment methodologies, the journal welcomes original research, reviews, and case studies that contribute valuable insights into clinical practice. Accessible without any open access restrictions, the journal has been a pivotal platform since its inception in 1997, facilitating knowledge exchange in the field up to 2024. As evidenced by its notable Scopus ranking within the top 73rd percentile of Psychiatry and Mental Health, it remains committed to impacting clinical practices significantly.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

Minerva Psychiatry is an innovative open-access journal published by EDIZIONI MINERVA MEDICA, focusing on the field of psychiatry and mental health. Launched in 2021, the journal aims to advance understanding and research in this critical area of medicine, serving as a platform for the dissemination of original research, clinical trials, and reviews that contribute to the improvement of mental health practices globally. With an ISSN of 2724-6612 and E-ISSN 2724-6108, this journal is situated in Italy and addresses a wide array of topics relevant to both practitioners and researchers in psychiatry. While the journal is currently ranked Q4 in its category, it seeks to enhance its impact by fostering high-quality submissions that address contemporary issues in mental health. Interested authors and readers can explore its publications through open access, encouraging a collective effort to elevate the standards and accessibility of psychiatric knowledge. With its commitment to nurturing a robust dialogue in the field, Minerva Psychiatry is positioned to become a valuable resource for those dedicated to mental health research and practice.

Australasian Psychiatry is a distinguished peer-reviewed journal published by SAGE Publications Ltd, focusing on the dynamic fields of Psychiatry and Mental Health. With a commendable Q3 ranking in the 2023 category quartiles, it serves as a vital resource for researchers, clinicians, and students alike, contributing to the understanding of mental health issues and advancements in psychiatric practice. Established in 1967, the journal has consistently disseminated original research, clinical reviews, and evidence-based practices, fostering a platform for discussing the contemporary challenges faced by mental health professionals. While operating from the heart of the United Kingdom, it aims to bridge regional insights with global trends, celebrating the diversity of thought in psychiatric discourse. Access to its rich content is through institutional subscriptions, ensuring that valuable research is within reach of dedicated scholars and mental health advocates. As the field evolves, Australasian Psychiatry remains committed to advancing knowledge and practice in mental health, positioning itself as an indispensable part of the academic landscape.

British Journal of Psychiatry, published by Cambridge University Press, stands as a pivotal resource in the realm of mental health and psychiatry. With an impressive impact reflected in its Q1 classifications in both Medicine (miscellaneous) and Psychiatry and Mental Health, this esteemed journal ranks 23rd out of 567 in its field according to Scopus, achieving an exceptional 96th percentile. Since its inception in 1963, the journal has continued to push the boundaries of research and discourse, serving as a platform for groundbreaking studies that enhance our understanding of psychiatric conditions and promote effective therapeutic strategies. Though it does not operate with an open-access model, the British Journal of Psychiatry remains an essential publication for researchers, clinicians, and students alike, offering in-depth insights and innovative findings that are crucial for navigating the complexities of mental health.

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

Early Intervention in Psychiatry, published by WILEY, is an esteemed academic journal dedicated to advancing the field of psychiatry and mental health through rigorous research and innovative practices. Established in 2007 and continuing through 2024, this journal serves as a critical resource for researchers, clinicians, and students interested in the early detection and treatment of psychiatric disorders. With an ISSN of 1751-7885 and an E-ISSN of 1751-7893, it is recognized for its significant contributions, placing in the Q3 quartile in Biological Psychiatry and Q2 in Psychiatry and Mental Health as of 2023. The journal boasts impressive Scopus rankings, being placed 12th in Nursing - Psychiatric Mental Health and 27th in Neuroscience - Biological Psychiatry, showcasing its impact within the scientific community. While not an open-access journal, its findings are pivotal for those seeking to enhance mental health interventions. Early Intervention in Psychiatry is committed to fostering knowledge and improving practices that ultimately contribute to better mental health outcomes globally.